Clinical trial · Interventional
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting in Pediatric Oncology Patients: a Randomized Controlled Trial
NCT06120764CI-TRIAL-00110157recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapy-induced Nausea and Vomiting | — | UNRESOLVED | — |
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| guided imagery | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Guided imagery group
- description
- Participants will receive guided imagery intervention.
- interventionNames
- Other: guided imagery
- type
- NO_INTERVENTION
- label
- Control
- description
- Participants will receive routine care.
Primary outcomes (1)
- measure
- Nausea and vomiting
- timeFrame
- 30 minutes before the procedure, halfway through the chemotherapy infusion, immediately after the procedure, and for the first 24 hours after the end of chemotherapy
- description
- Nausea and Vomiting Thermometer Scale in Children with Cancer is a 5-likert type scale. An increase in the score indicates an increase in the degree of nausea and vomiting experienced by children with cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 7 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 7 to 18 years old, * who will receive intravenous chemotherapy, * no cognitive or neurological disease that would prevent communication, * receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification, * no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency), * children whose parents and themselves volunteered to participate in the study Exclusion Criteria: * Children receiving radiotherapy, * taking ginger powder or vitamins to reduce nausea, * children who did not want to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.